Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer treated without elective nodal irradiation

Medical Dosimetry

Volumn 36, Issue 4, 2011, Pages 440-447

  Ahmed, Irfan ^a   DeMarco, Marylou ^a   Stevens, Craig W ^a   Fulp, William J ^a   Dilling, Thomas J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Elective nodal irradiation; PET CT scan; Selective nodal irradiation; Small cell lung cancer

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; ELECTIVE NODAL IRRADIATION; ESOPHAGUS; HUMAN; INCIDENTAL RADIATION DOSE; LIMITED STAGE LUNG SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE; LYMPH NODE IRRADIATION; MEDIASTINUM DISEASE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; SPINAL CORD; SUPRACLAVICULAR LYMPH NODE; TREATMENT PLANNING; TUMOR VOLUME;

FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; MEDIASTINUM; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SMALL CELL LUNG CARCINOMA;

EID: 80755135510     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2010.11.002     Document Type: Article

References (28)

1. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell Lung Cancer in the U.S. over the last 30 yrs: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol. 2006, 24:4539-4544.
2. Turrisi A., Glover D., Mason B.A. preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1988, 15:183-187.
3. Zelen M. Keynote address on biostatistics and data retrieval. Cancer. Chemother. Rep. (part 3) 1973, 4:31-42.
4. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J. Med. 1999, 340:265-271.
5. Choi N.C., Herndon J.E., Rosenman J., et al. Phase 1 study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J. Clin. Oncol. 1998, 16:3528-3536.
6. Dwamena B.A., Sonnad S.S., Angobaldo J.O., Wahl R.L. Metastases from nonsmall cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 1999, 213:530-536.
7. Gould M.K., Kuschner W.G., Rydzak C.E., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with nonsmall-cell lung cancer: a meta-analysis. Ann. Intern. Med. 2003, 139:879-892.
8. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62(1):70-75.
9. Steenbakkers R.J.H.M., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64(2):435-448.
10. Kong F.L., Gaspar L., Komaki R. Patterns of practice in radiation dose prescription and treatment planning for patients with lung cancer among members of American Society of Therapeutic Radiology and Oncology. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:S483.
11. Yuan S., Sun X., Li M.H., et al. A randomized study of involved field irradiation vs. elective nodal irradiation in combination with concurrent chemotherapy for inperable stage 3 nonsmall cell lung cancer. Am. J. Clin. Oncol. 2007, 30:239-244.
12. Rosenzweig K.E., Sura S., Jackson A., Yorke E. Involved-field radiation therapy for inoperable nonsmall-cell lung cancer. J. Clin. Oncol. 2007, 25:5557-5561.
13. Sulman E., Komaki R., Klopp A., Cox J., Chang J. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in nonsmall cell lung cancer. Radiat. Oncol. 2009, 4:5.
14. Belderbos J.S.A., Jaeger K.D., Heemsbergen W.D., et al. First results of a phase 1/2 dose escalation trial in nonsmall cell lung cancer using three-dimensional conformal radiotherapy. Radiother. Oncol. 2003, 66(2):119-126.
15. Martel M.K., Sahijdak W.M., Hayman J.A. Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer. Int. J. Radiol. Oncol. J. Biol. Phys. 1999, 45:S244.
16. Lujun Z., Ming C., Randall T.H., et al. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative nonsmall cell lung cancer when the tumor is large and centrally located. Radiother. Oncol. 2007, 82(2):153-159.
17. DeRuysscher D., Bremer R.-H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase 2 trial. Radiother. Oncol. 2006, 80:307-312.
18. Colaco R.J., Sheikh H.Y., Lorigan P.C., et al. Omitting ENI during thoracic irradiation in LS-SCLC - patterns of failure from a phase 2 trial. Lung World Conference 2009, San Francisco, CA.
19. Chapet O., Kong F.M., Quint L.E., et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int. J. Radiol. Oncol. J. Biol. Phys. 2005, 63:170-178.
20. Madu C.N., Quint D.J., Normolle D.P., Marsh R.B., Wang E.Y., Pierce L.J. Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy. Radiology 2001, 221:333-339.
21. VanLoon J., Offermann C., Bosmans G., et al. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiat. Ther. Oncol. 2008, 87:49-54.
22. Videtic G., Belderbos J., Spring Kong F., Kepka L., Martel M., Jeremic B. Report from the International Atomic Energy Agency consultants' meeting on eelctive nodal irradiation in lung cancer: SCLC. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72(2):327-334.
23. Bradley J.D., Dehdashti F., Mintun M.A., Govindan R., Trinkaus K., Siegel B.A. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J. Clin. Oncol. 2004, 22:3248-3254.
24. Fischer B., Mortensen J., Langer S. A. prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann. Oncol. 2007, 18:338-345.
25. Hauber H., Bohuslavizki K., Lund C. Positron emission tomography in the staging of small-cell lung cancer. Chest 2001, 119:950-954.
26. Schumacker T., Brink I., Mix M. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur. J. Nucl. Med. 2001, 28:483-488.
27. Shen Y., Shiau Y., Wang J. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging Smal cell lung cancer. Anticancer. Res. 2002, 22:1257-1264.
28. VanLoon J., De Ruysscher D., Wanders R., et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77(2):329-336.